alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3315 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  1st Session
                                S. 3315

 To amend the Endangered Species Act of 1973 to require disclosure to 
States of the basis of determinations under that Act, to ensure use of 
    information provided by State, Tribal, and local governments in 
        decision making under that Act, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            December 6, 2021

   Ms. Lummis (for herself, Mr. Barrasso, Mr. Crapo, and Mr. Risch) 
introduced the following bill; which was read twice and referred to the 
               Committee on Environment and Public Works

_______________________________________________________________________

                                 A BILL

 
 To amend the Endangered Species Act of 1973 to require disclosure to 
States of the basis of determinations under that Act, to ensure use of 
    information provided by State, Tribal, and local governments in 
        decision making under that Act, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``State, Tribal, and Local Species 
Transparency and Recovery Act''.

SEC. 2. REQUIRING DECISIONAL TRANSPARENCY WITH AFFECTED STATES.

    Section 6(a) of the Endangered Species Act of 1973 (16 U.S.C. 
1535(a)) is amended--
            (1) in the first sentence, by striking ``In carrying out'' 
        and inserting the following:
            ``(1) In carrying out''; and
            (2) in paragraph (1) (as so designated), in the second 
        sentence, by striking ``Such cooperation shall include'' and 
        inserting the following:
    ``(2) Cooperation under paragraph (1) shall include--
            ``(A) before making a determination under section 4(a), 
        providing to States affected by that determination all data 
        that is the basis of the determination; and
            ``(B)''.

SEC. 3. ENSURING USE OF STATE, TRIBAL, AND LOCAL INFORMATION.

    (a) In General.--Section 3 of the Endangered Species Act of 1973 
(16 U.S.C. 1532) is amended--
            (1) by redesignating paragraphs (2) through (21) as 
        paragraphs (3) through (22), respectively; and
            (2) by inserting after paragraph (1) the following:
    ``(2) The term `best scientific and commercial data available' 
includes all of the best available scientific and commercial data 
submitted by a State, Tribal, or local government.''.
    (b) Conforming Amendment.--Section 7(n) of the Endangered Species 
Act of 1973 (16 U.S.C. 1536(n)) is amended, in the first sentence, by 
striking ``, as defined by section 3(13) of this Act,''.
                                 <all>
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Homeland Security

###### Federal Emergency Management Agency

          - [Internal Agency Docket No. FEMA-4246-DR; Docket ID FEMA-2016-0001]

# AGENCY:

Federal Emergency Management Agency, DHS.

# ACTION:

Notice.

# SUMMARY:

This notice amends the notice of a major disaster declaration for State of Idaho (FEMA-4246-DR), dated December 23, 2015, and related determinations.

# DATES:

*Effective Date:*                         January 20, 2016.                    

# FOR FURTHER INFORMATION CONTACT:

Dean Webster, Office of Response and Recovery, Federal Emergency Management Agency, 500 C Street SW., Washington, DC 20472, (202) 646-2833.

      ( print page 6032)    

# SUPPLEMENTARY INFORMATION:

The Federal Emergency Management Agency (FEMA) hereby gives notice that pursuant to the authority vested in the Administrator, under Executive Order 12148, as amended, Dolph A. Diemont, of FEMA is appointed to act as the Federal Coordinating Officer for this disaster.

This action terminates the appointment of Thomas J. Dargan as Federal Coordinating Officer for this disaster.

The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster Legal Services; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048, Disaster Housing Assistance to Individuals and Households In Presidentially Declared Disaster Areas; 97.049, Presidentially Declared Disaster Assistance—Disaster Housing Operations for Individuals and Households; 97.050, Presidentially Declared Disaster Assistance to Individuals and Households—Other Needs; 97.036, Disaster Grants—Public Assistance (Presidentially Declared Disasters); 97.039, Hazard Mitigation Grant.

W. Craig Fugate,

Administrator, Federal Emergency Management Agency.

[FR Doc. 2016-02024 Filed 2-3-16; 8:45 am]

 BILLING CODE 9111-23-P
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 1998 10K
DATED DECEMBER 31, 1998 AND IS QUALIFIED INITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             DEC-28-1997
<PERIOD-END>                               DEC-31-1998
<CASH>                                          19,495
<SECURITIES>                                       978
<RECEIVABLES>                                    4,439
<ALLOWANCES>                                       556
<INVENTORY>                                          0
<CURRENT-ASSETS>                                25,490
<PP&E>                                           1,025<F1>
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  28,317<F2>
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           249
<OTHER-SE>                                      21,923
<TOTAL-LIABILITY-AND-EQUITY>                    28,317
<SALES>                                         18,367
<TOTAL-REVENUES>                                18,367
<CGS>                                            4,679
<TOTAL-COSTS>                                   21,642
<OTHER-EXPENSES>                              (10,998)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   3
<INCOME-PRETAX>                                  7,723
<INCOME-TAX>                                       446
<INCOME-CONTINUING>                              7,277
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     7,277
<EPS-PRIMARY>                                     0.31
<EPS-DILUTED>                                     0.29
<FN>
<F1>PP&E IS NET OF ACCUMULATED DEPRECIATION OF $2,690
<F2>TOTAL ASSETS INCLUDE $365 OF OTHER ASSETS AND INVESTMENTS OF 1,437
</FN>
        

</TABLE>
Skip to main content

# Social Security

Search
Menu
Español
Sign in

## Contributions by Program & Source

Office of the Chief Actuary 

Statistical Tables

**Contributions to the Social Security and Medicare Trust Funds,    by program and source, 2014-2023 (in millions of dollars)**

Footer menu
**Exhibit 31.2****CERTIFICATIONS**I, Mark P. O’Neill, certify that: 1. I have reviewed this Form 10-QSB of Hypertension Diagnostics, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to theperiod covered by this report;  3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the small business issuer as of, and for, theperiods presented in this report;  4. The small business issuer’s other certifying officer(s) and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the small business issuer and have:(a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure thatmaterial information relating to the small business issuer, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;(b) Evaluated the effectiveness of the small business issuer’s disclosure controlsand procedures and presented in this report our conclusions about the effectivenessof the disclosure controls and procedures, as of the end of the period covered bythis report based on such evaluation; and(c) Disclosed in this report any change in the small business issuer’s internalcontrol over financial reporting that occurred during the small business issuer’smost recent fiscal quarter (the small business issuer’s fourth fiscal quarter in thecase of an annual report) that has materially affected, or is reasonably likely tomaterially affect, the small business issuer’s internal control over financialreporting; and 5. The small business issuer’s other certifying officer(s) and I have disclosed, based onour most recent evaluation of internal control over financial reporting, to the smallbusiness issuer’s auditors and the audit committee of the small business issuer’s board ofdirectors (or persons performing the equivalent functions):(a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely toadversely affect the small business issuer’s ability to record, process, summarizeand report financial information; and(b) Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the small business issuer’s internal control overfinancial reporting.                                                       /s/ Mark P. O’Neill   Mark P. O’Neill   Manager of Finance and Accounting (principalfinancial officer)   Date: May 14, 2007
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Apple REIT Eight, Inc., (the "Company") on Form 10-K for the year
ending December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned hereby certifies, pursuant to 18 U.S.C Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities and
Exchange Act of 1934; and (2) the information contained in the Report fairly represents, in all material respects, the financial conditions and results of operations of the Company as of
December 31, 2009, and for the period then ended.

/s/ GLADE M. KNIGHT Glade M. Knight
Chief Executive Officer/s/ BRYAN PEERY Bryan Peery
Chief Financial OfficerMarch 5, 2010


---



QuickLinks
733 A.2d 492

#### STATE OF NEW JERSEY, PLAINTIFF-MOVANT, v. STEVEN FORTIN, DEFENDANT-RESPONDENT.

April 30, 1999.

Leave to appeal is granted.
[Federal Register Volume 60, Number 246 (Friday, December 22, 1995)]
[Notices]
[Page 66577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-31164]



-----------------------------------------------------------------------


DEPARTMENT OF THE TREASURY

Proposed Agency Information Collection Activities; Comment 
Request

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: The Department of the Treasury, as part of its continuing 
effort to reduce paperwork and respondent burden, invites the general 
public and other Federal agencies to take this opportunity to comment 
on proposed and/or continuing information collections, as required by 
the Paperwork Reduction Act of 1995, Public Law 104-13 (44 U.S.C. 
3506(c)(2)(A)). Currently, the Bureau of Alcohol, Tobacco and Firearms 
within the Department of the Treasury is soliciting comments concerning 
the Distilled Spirits Plants Excise Taxes.

DATES: Written comments should be received on or before February 20, 
1996 to be assured of consideration.

ADDRESSES: Direct all written comments to Bureau of Alcohol, Tobacco 
and Firearms, Linda Barnes, 650 Massachusetts Avenue, NW., Washington, 
DC 20226, (202) 927-7768.

FOR FURTHER INFORMATION CONTACT: Requests for additional information or 
copies of the form(s) and instructions should be directed to Tami 
Light, Wine, Beer and Spirits Regulations Branch, 650 Massachusetts 
Avenue, NW., Washington, DC 20226, (202) 927-8210.

SUPPLEMENTARY INFORMATION:
    Title: Distilled Spirits Plants, Excise Taxes.
    OMB Number: 1512-0203.
    Recordkeeping Requirement ID Number: ATF REC 5110/06.
    Abstract: The collection of information is necessary to account for 
and verify taxable removals of distilled spirits. The data is used to 
audit tax payments.
    Current Actions: There are no changes to this information 
collection and it is being submitted for extension purposes only.
    Type of Review: Extension.
    Affected Public: Business or other for-profit.
    Estimated Number of Respondents: 133.
    Estimated Time Per Respondent: 26 hours.
    Estimated Total Annual Burden Hours: 3458.

REQUEST FOR COMMENTS: Comments submitted in response to this notice 
will be summarized and/or included in the request for OMB approval. All 
comments will become a matter of public record. Written comments should 
address the accuracy of the burden estimates and ways to minimize 
burden including the use of automated collection techniques or the use 
of other forms of information technology, as well as other relevant 
aspects of the information collection request.

DATED: December 15, 1995.
John W. Magaw,
Director.
[FR Doc. 95-31164 Filed 12-21-95; 8:45 am]
BILLING CODE 4810-31-P
#### EAST CAROLINA RAILWAY v. F. J. McGUIRE et al.

(Filed 14 September, 1927.)

Appeal by defendant, E. L. McGuire, from *Barnhill, J.,*’at March Term, 1927, of Edgeoombe.

Motion filed 18 October, 1926, by F. J. McGuire to set aside a judgment rendered on a verdict at the March Term, 1926, Edgecombe Superior Court. Motion denied 14 March, 1927. Movant appeals.

*789
      *John L. Bridgers and Hewry G. Bourne for plaintiff.*

*Whedbee & Whedbee for defendant, F. J. McGuire, appellant.*

Per Curiam:.

This is an appeal from a refusal to set aside a judgment on tbe ground of “mistake, inadvertence, surprise or excusable neglect.” C. S., 600.

Tbe judge, upon competent evidence, found facts from wbicb be concluded, first, tbat tbe movant bad failed to show any excusable neglect; and, second, tbat no meritorious defense bad been made to appear. There is nothing on tbe record to warrant a reversal of tbe judgment. *Taylor v. Gentry,*192 N. c., 503; *cahoon v. Brinkley,*176 N. C., 5; *Norton v. McLaurin,*125 N. C., 185.

Affirmed.
<PAGE>


                                                                    EXHIBIT 21.3

                               VERTEL CORPORATION
                         SUBSIDIARIES OF THE REGISTRANT


                                                      Other Name(s)
                                 Jurisdiction        Under Which the
                                     of              Subsidiary Does
Name of Subsidiary              Incorporation           Business
-----------------------         -------------     --------------------

   Vertel Pacific               California        Vertel Asia Pacific,
                                                  Vertel Korea
                                                  Vertel Japan

   Vertel B.V.                  Netherlands       Retix Ireland, Vertel Ireland,
                                                     Vertel France, Vertel
                                                     Germany, Vertel U.K.
                                                     Retix B.V.

   Vertel U.K. Limited          United Kingdom    Retix Property Company, Ltd.

   Vertel Germany GmbH          Germany           Retix (Deutschland) GmbH

   Vertel Poland Sp. z o.o      Poland            None

   Recodif Retix France (TM)    France            None
EXHIBIT 32.2
                           SECTION 1350 CERTIFICATION

                           CERTIFICATION PURSUANT TO\
                 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the quarterly report of Alec Bradley Cigar
Corporation (the "Company") on Form 10-QSB for the period ended September 30,
2003 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Alan Rubin, Principal Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

         1. The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         2. The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.



Date: November 11, 2003


/s/ Alan Rubin
--------------
Alan Rubin
Principal Financial Officer
II 

117TH CONGRESS 

1ST SESSION S. 3279 

To extend duty-free treatment provided with respect to imports from Haiti 

under the Caribbean Basin Economic Recovery Act. 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 30, 2021 

Mr. RUBIO (for himself and Mr. CASSIDY) introduced the following bill; which 

was read twice and referred to the Committee on Finance 

A BILL 

To extend duty-free treatment provided with respect to imports from Haiti under the Caribbean Basin Economic 

Recovery Act. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Haiti Economic Lift 

5 Program Extension Act of 2021’’. 

6 SEC. 2. EXTENSION OF SPECIAL RULES FOR HAITI UNDER 

7 CARIBBEAN BASIN ECONOMIC RECOVERY 

8 ACT. 

9 Section 213A of the Caribbean Basin Economic Re10 covery Act (19 U.S.C. 2703a) is amended— 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 3279 IS

1 (1) in subsection (b)(1)— 

2 (A) in subparagraph (B)(v)(I)— 

3 (i) by striking ‘‘means’’ and all that 

4 follows through ‘‘60 percent’’ and inserting 

5 ‘‘means 60 percent’’; and 

6 (ii) by striking ‘‘7 succeeding 1-year 

7 periods’’ and inserting ‘‘17 succeeding 1- 

8 year periods’’; and 

9 (B) in subparagraph (C)— 

10 (i) in the table, by striking ‘‘16 suc11 ceeding 1-year periods’’ and inserting ‘‘28 

12 succeeding 1-year periods’’; and 

13 (ii) in the matter following the table, 

14 by striking ‘‘2025’’ and inserting ‘‘2035’’; 

15 and 

16 (2) in subsection (h), by striking ‘‘2025’’ and 

17 inserting ‘‘2035’’. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
[Federal Register Volume 60, Number 244 (Wednesday, December 20, 1995)]
[Notices]
[Page 65638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30944]



-----------------------------------------------------------------------


DEPARTMENT OF COMMERCE

Prospective Grant of Exclusive Patent License; Pasadena 
Scientific Industries

AGENCY: National Institute of Standards and Technology, Commerce.

ACTION: Notice of prospective grant of exclusive patent license.

-----------------------------------------------------------------------

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i) that the National Institute of Standards and 
Technology (``NIST''), U.S. Department of Commerce, is contemplating 
the grant of a field of use exclusive license in the United States to 
practice the invention embodied in U.S. Patent Number 5,389,523, 
titled, ``Liposome Immunoanalysis By Flow Injection Assay'' to Pasadena 
Scientific Industries, having a place of business in Hanover, Maryland.

FOR FURTHER INFORMATION CONTACT: Bruce E. Mattson, National Institute 
of Standards and Technology, Technology Development and Small Business 
Program, Building 221, Room B-256, Gaithersburg, MD 20899.

SUPPLEMENTARY INFORMATION: The prospective exclusive license will be 
royalty-bearing and will comply with the terms and conditions of 35 
U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be 
granted unless, within sixty days from the date of this published 
Notice, NIST receives written evidence and argument which establish 
that the grant of the license would not be consistent with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
    U.S. Patent Number 5,389,523 is a method of immunoanalysis which 
combines immobilized immunochemistry with the technique of flow 
injection analysis, and employs microscopic spherical structures called 
liposomes, or lipid vesicles, as carriers of detectable reagents.
    NIST may enter into a Cooperative Research and Development 
Agreement (``CRADA'') to perform further research on the invention for 
purposes of commercialization. The CRADA may be conducted by NIST 
without any additional charge to any party that licenses the patent. 
NIST may grant the licensee an option to negotiate for royalty-free 
exclusive licenses to any jointly owned inventions which arise from the 
CRADA as well as an option to negotiate for exclusive royalty-bearing 
licenses for NIST employee inventions which arise from the CRADA.
    The availability of the invention for licensing was published in 
the Federal Register, Vol. 57, No. 226 (November 23, 1992). A copy of 
the patent application may be obtained from NIST at the foregoing 
address.

    Dated: December 14, 1995.
Samuel Kramer,
Associate Director.
[FR Doc. 95-30944 Filed 12-19-95; 8:45 am]
BILLING CODE 3510-13-M